Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
-5.86% $3.05
America/New_York / 16 jun 2021 @ 00:00
FUNDAMENTALS | |
---|---|
MarketCap: | 5.47 mill |
EPS: | -1.376 |
P/E: | -2.22 |
Earnings Date: | May 12, 2021 |
SharesOutstanding: | 1.794 mill |
Avg Daily Volume: | 1.508 mill |
RATING 2022-02-09 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Buy | |
P/E: | Strong Sell | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/20 | 2/20 | 3/20 | 4/20 | 1/21 | 2/21 | |
Revenue | n/a | |||||
Gr.Profit | n/a | |||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -2.22 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.01x |
Company: PE -2.22 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 2.39 - 3.72 ( +/- 21.80%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2020-09-16 | Stevenson Sharon | Buy | 27 250 | Stock Option (Right to Buy) |
2020-09-16 | Stevenson Sharon | Buy | 27 250 | Stock Option |
2020-09-16 | Dittamore Raymond V | Buy | 27 250 | Stock Option |
2020-09-16 | Dittamore Raymond V | Buy | 27 250 | Stock Option (Right to Buy) |
2020-06-23 | Hussainy Nooshin | Buy | 165 135 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
0.00 |
Last 98 transactions |
Buy: 7 631 252 | Sell: 41 791 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $3.05 (-5.86% ) |
Volume | 26.47 mill |
Avg. Vol. | 1.508 mill |
% of Avg. Vol | 1 755.21 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.